Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

Affiliations

¹ Division of Hematology, Department of Oncology, McMaster University, Hamilton, ON, Canada. Electronic address: hira.mian@medportal.ca.
² Division of Hematology-Oncology, Department of Medicine, University of Washington-Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ Hematology and Oncology Department, Interdisciplinary Cancer Center (ITZ), Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg, Hugstetterstr. 53, 79106 Freiburg, Germany.
⁴ The Institute of Cancer Research and Royal Marsden Hospital NHS Foundation Trust, London, UK.
⁵ SSD Clinical Trial in onco-ematologia e mieloma multiplo, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
⁶ Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
⁷ Division of Hematology, The Ohio State University, Columbus, OH, USA.
⁸ Klinik für Innere Medizin II, Universitätsklinikum Jena, Leibniz-Institut für Naturstoff Forschung und Infektionsbiologie, Hans-Knöll Institut, Jena, Germany.
⁹ Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Hira Mian et al. J Geriatr Oncol. 2020 Jun.

. 2020 Jun;11(5):764-768.

doi: 10.1016/j.jgo.2020.04.008. Epub 2020 Apr 17.

¹ Division of Hematology, Department of Oncology, McMaster University, Hamilton, ON, Canada. Electronic address: hira.mian@medportal.ca.
² Division of Hematology-Oncology, Department of Medicine, University of Washington-Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ Hematology and Oncology Department, Interdisciplinary Cancer Center (ITZ), Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg, Hugstetterstr. 53, 79106 Freiburg, Germany.
⁴ The Institute of Cancer Research and Royal Marsden Hospital NHS Foundation Trust, London, UK.
⁵ SSD Clinical Trial in onco-ematologia e mieloma multiplo, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
⁶ Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
⁷ Division of Hematology, The Ohio State University, Columbus, OH, USA.
⁸ Klinik für Innere Medizin II, Universitätsklinikum Jena, Leibniz-Institut für Naturstoff Forschung und Infektionsbiologie, Hans-Knöll Institut, Jena, Germany.
⁹ Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

No abstract available

Figures

1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. - PubMed
1. Zhang L., Zhu F., Xie L., Wang C., Wang J., Chen R., et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Mar 26 doi: 10.1016/j.annonc.2020.03.296. - DOI - PMC - PubMed
1. Wang L., He W., Yu X., Hu D., Bao M., Liu H., et al. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020 Mar;30 - PMC - PubMed
1. Omer S.B., Malani P., Del Rio C. The COVID-19 pandemic in the US: a clinical update. JAMA. 2020 Apr;6 - PubMed
1. Coronavirus Resource Center: John Hopkins University and Medicine https://coronavirus.jhu.edu/map.html [accessed 13 April 2020]